Literature DB >> 25391919

Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.

Ying Liu1, Tao Xin, Da-yong Huang, Wei-xi Shen, Li Li, Yan-ju Lv, Ying-hua Jin, Xiao-wei Song, Chong Teng, Qiu-ying Jiang.   

Abstract

The aim of this investigation was to compare clinical pathological characteristics and prognosis of very young and older triple-negative breast cancer (TNBC) patients in order to assess their relevance to TNBC in an younger population. Data of TNBC patients diagnosed between 2002 and 2007 were retrospectively analyzed by computer based chart information. Baseline tumor characteristics, biological markers, and patients' prognosis were compared between very young (≤ 35 years) and older (>35 years) TNBC patients. In the 216 cases of operable TNBC patients, 48 (22.2%) were ≤ 35 years and 168 (77.8%) were >35 years. Very young TNBC patients had showed a high clinical stage, more positive lymph nodes, Ck5/6 and/or EGFR expression (P = 0.049, 0.006, and 0.011, respectively). Compared to older TNBC patients, very young TNBC patients have short disease-free survival (P = 0.031), while no significant difference was found in overall survival (OS) (P = 0.075). In multivariate analysis, lymph node metastatic status was a significant predictor of OS. TNBC of very young patients is an aggressive breast cancer subtype, but the overall survival of both young and older TNBC patients did not have significant differences.

Entities:  

Mesh:

Year:  2014        PMID: 25391919     DOI: 10.1007/s12032-014-0222-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  24 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.

Authors:  Robert Königsberg; Georg Pfeiler; Tatjana Klement; Nicole Hammerschmid; Andreas Brunner; Robert Zeillinger; Christian Singer; Christian Dittrich
Journal:  Eur J Cancer       Date:  2012-05-28       Impact factor: 9.162

3.  Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

Authors:  X Du; J S Goodwin
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

4.  Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.

Authors:  Mara A Schonberg; Edward R Marcantonio; Donglin Li; Rebecca A Silliman; Long Ngo; Ellen P McCarthy
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

5.  Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

Authors:  Hyman B Muss; Susan Woolf; Donald Berry; Constance Cirrincione; Raymond B Weiss; Daniel Budman; William C Wood; I Craig Henderson; Clifford Hudis; Eric Winer; Harvey Cohen; Judith Wheeler; Larry Norton
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

6.  Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Authors:  Torsten O Nielsen; Forrest D Hsu; Kristin Jensen; Maggie Cheang; Gamze Karaca; Zhiyuan Hu; Tina Hernandez-Boussard; Chad Livasy; Dave Cowan; Lynn Dressler; Lars A Akslen; Joseph Ragaz; Allen M Gown; C Blake Gilks; Matt van de Rijn; Charles M Perou
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

7.  Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

Authors:  Roberto Gennari; Giuseppe Curigliano; Nicole Rotmensz; Chris Robertson; Marco Colleoni; Stefano Zurrida; Franco Nolè; Filippo de Braud; Laura Orlando; Maria Cristina Leonardi; Viviana Galimberti; Mattia Intra; Paolo Veronesi; Giuseppe Renne; Saverio Cinieri; Riccardo A Audisio; Alberto Luini; Roberto Orecchia; Giuseppe Viale; Aron Goldhirsch
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

8.  Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.

Authors:  Hirotaka Iwase; Junichi Kurebayashi; Hitoshi Tsuda; Tomohiko Ohta; Masafumi Kurosumi; Kazuaki Miyamoto; Yutaka Yamamoto; Takuji Iwase
Journal:  Breast Cancer       Date:  2009-05-23       Impact factor: 4.239

9.  Breast carcinomas occurring in young women (< 35 years) are different.

Authors:  R A Walker; E Lees; M B Webb; S J Dearing
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Authors:  A Goldhirsch; J N Ingle; R D Gelber; A S Coates; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2009-06-17       Impact factor: 32.976

View more
  7 in total

1.  Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.

Authors:  Jidong Xiao; Yuanquan Zhou; Wenhui Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Correlation of NGX6 expression with clinicopathologic features and prognosis in colon cancer.

Authors:  Jidong Xiao; Yuanquan Zhou; Bo Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation.

Authors:  H Vihervuori; K Korpinen; T A Autere; H Repo; K Talvinen; P Kronqvist
Journal:  Breast Cancer Res Treat       Date:  2022-10-19       Impact factor: 4.624

4.  Concurrent BRAF and PTEN mutations in melanoma of unknown origin presenting as a breast mass.

Authors:  Emmanuel Agosto-Arroyo; Marilin Rosa; Alec Chau; Laila Khazai
Journal:  SAGE Open Med Case Rep       Date:  2017-05-31

5.  The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study.

Authors:  Dongjun Dai; Yiming Zhong; Zhuo Wang; Neelum Aziz Yousafzai; Hongchuan Jin; Xian Wang
Journal:  PeerJ       Date:  2019-07-04       Impact factor: 2.984

Review 6.  Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature.

Authors:  Ian Landry; Vikram Sumbly; Mallorie Vest
Journal:  Cureus       Date:  2022-02-07

Review 7.  Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness.

Authors:  Rinad Mahmoud; Paloma Ordóñez-Morán; Cinzia Allegrucci
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.